Explore peer-reviewed insights spanning clinical research, public health, biotechnology, neuroscience, and pharmacology. Updated daily by verified experts worldwide.
Recent longitudinal studies reveal bidirectional communication pathways between intestinal flora and neural networks, suggesting new therapeutic avenues for neurodegenerative conditions.
A comprehensive analysis of Phase I/II gene-editing trials, evaluating off-target effects, delivery mechanisms, and evolving FDA/EMA compliance frameworks.
Examining longitudinal adoption rates across healthcare systems, highlighting disparities in rural access and the economic viability of virtual care models.
CAR-T cell advancements, bispecific antibodies, and cancer vaccines are reshaping treatment paradigms for hematologic and solid tumors.
Machine learning frameworks integrating meteorological data, mosquito population dynamics, and human mobility patterns to forecast outbreak risks.
How genetic profiling is reducing trial-and-error prescribing in depression and schizophrenia management, improving patient outcomes.
Chronic sleep architecture fragmentation correlates with accelerated amyloid-beta accumulation, raising concerns for occupational neurotoxicity.
Integration of transcriptomic, proteomic, and metabolomic signatures enables sub-hour identification of septic shock, improving survival rates.
Task-shifting strategies, digital therapeutics, and community health worker training models demonstrate efficacy in bridging global care gaps.
P-tau217 and NfL assays show diagnostic accuracy rivaling PET imaging, promising non-invasive early screening protocols.